Publicaciones en las que colabora con David Otaegui Bichot (33)

2024

  1. Centenarian hippocampus displays high levels of astrocytic metallothioneins

    Aging Cell, Vol. 23, Núm. 8

2023

  1. Blood RNA-Seq profiling reveals a set of circular RNAs differentially expressed in frail individuals

    Immunity and Ageing, Vol. 20, Núm. 1

2022

  1. Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis

    Frontiers in Immunology, Vol. 13

  2. The innovative animal monitoring device for experimental autoimmune encephalomyelitis (“I AM D EAE”): A more detailed evaluation for improved results

    Multiple Sclerosis and Related Disorders, Vol. 63

2021

  1. Gut microbiota changes in experimental autoimmune encephalomyelitis and cuprizone mice models

    ACS Chemical Neuroscience, Vol. 12, Núm. 5, pp. 893-905

  2. O group is a protective factor for COVID19 in Basque population

    PLoS ONE, Vol. 16, Núm. 4 April

  3. Profiling of plasma extracellular vesicle transcriptome reveals that circrnas are prevalent and differ between multiple sclerosis patients and healthy controls

    Biomedicines, Vol. 9, Núm. 12

2020

  1. MiR-219a-5p enriched extracellular vesicles induce OPC differentiation and EAE improvement more efficiently than liposomes and polymeric nanoparticles

    Pharmaceutics, Vol. 12, Núm. 2

  2. RNA-Seq profiling of leukocytes reveals a sex-dependent global circular RNA upregulation in multiple sclerosis and 6 candidate biomarkers

    Human Molecular Genetics, Vol. 29, Núm. 20, pp. 3361-3372

  3. Whole-transcriptome analysis in peripheral blood mononuclear cells from patients with lipid-specific oligoclonal igm band characterization reveals two circular RNAs and two linear rnas as biomarkers of highly active disease

    Biomedicines, Vol. 8, Núm. 12, pp. 1-16

2019

  1. CHAPTER 13: Non-coding RNA and Multiple Sclerosis: New Targets for Drug Discovery

    RSC Drug Discovery Series (Royal Society of Chemistry), pp. 285-301

  2. T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians

    Aging, Vol. 11, Núm. 22, pp. 10723-10741

2018

  1. Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old

    Frontiers in Aging Neuroscience, Vol. 10

  2. The first dose of fingolimod affects circulating extracellular vesicles in multiple sclerosis patients

    International Journal of Molecular Sciences, Vol. 19, Núm. 8

  3. Therapeutic potential of extracellular vesicles for demyelinating diseases; Challenges and opportunities

    Frontiers in Molecular Neuroscience

2017

  1. Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis

    Human Molecular Genetics, Vol. 26, Núm. 18, pp. 3564-3572

  2. Models for Studying Myelination, Demyelination and Remyelination

    NeuroMolecular Medicine, Vol. 19, Núm. 2-3, pp. 181-192

  3. Progressive changes in non-coding RNA profile in leucocytes with age

    Aging, Vol. 9, Núm. 4, pp. 1202-1218

2016

  1. Ferritin-mediated siRNA delivery and gene silencing in human tumor and primary cells

    Biomaterials, Vol. 98, pp. 143-151

  2. Inflammaging and frailty status do not result in an increased extracellular vesicle concentration in circulation

    International Journal of Molecular Sciences, Vol. 17, Núm. 7